Related Experiment Video
Updated: Nov 6, 2025

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
Cutaneous Manifestation as Initial Presentation of Metastatic Breast Cancer: A Systematic Review
Cassandra Johnson1, Daniel P Friedmann1, Anita Gade1
1Drs. Johnson, Hinchee-Rodriguez, and Apicella and Mr. Dhawan are from Nova Southeastern University, Fort Lauderdale, Florida. Dr. Friedmann is from Westlake Dermatology Clinical Research Center, Austin, Texas. Dr. Gade is from the New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York. Dr. Mishra is from University of Texas Health San Antonio. Dr. Rodriguez is from the Long School of Medicine, University of Texas Health San Antonio.
Abstract:
Metastatic breast cancer initially may present with cutaneous lesions. The goal of this systematic review was to evaluate available reports where the initial discovery of primary breast cancer occurred through the diagnosis of metastatic cutaneous lesions. We aimed to better understand these cases and the role of dermatologists in their diagnosis. A review of the literature for case reports and retrospective studies was conducted using the following databases: MEDLINE/PubMed, EMBASE, Cochrane library, CINAHL, and EBSCO. The PRISMA guidelines were utilized. Studies were included if they reported a cutaneous metastasis of a primary breast cancer in females. Studies were excluded if skin metastasis occurred in a patient with a history of breast cancer. Thirty-six publications were identified. Among these, 27 were case reports, and 9 were retrospective reviews. An enhanced understanding of how these cutaneous metastases present may be of clinical benefit to physicians, particularly dermatologists.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

